What's New

  • 13 Dec 2018
    Antares Pharma Announces The Appointment of Peter S. Greenleaf To Company's Board of Directors Read More

  • 29 Nov 2018
    Antares Pharma Announces The Commercial Availability Of XYOSTED™ (Testosterone Enanthate ) Injection – A New Treatment For Adult Men Diagnosed With Testosterone Deficiency Read More

  • 27 Nov 2018
    Antares Pharma Partner TEVA Announces Commercial Availability of Generic EpiPen Read More

ATRS

Quotes delayed at least 15 minutes